Johnson & Johnson bags Spravato approval despite concerns - Vantage

Submitted by Anonymous (not verified) on Wed, 03/06/2019 - 12:00

Johnson & Johnson bags Spravato approval despite concerns  VantageJohnson & Johnson has brushed aside controversy, with its novel antidepressant Spravato (esketamine) winning US FDA approval yesterday. Safety and abuse ...